Granon 3mg/3ml injection
Dexa Medica
Ingredients in every 3 ml
| Granisetron | 3 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | A - Alimentary tract and metabolism |
| ATC Level 2 | A04 - Antiemetics and Antinauseants |
| ATC Level 3 | A04A - Antiemetics and Antinauseants |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
Dosage information
18 YEARS OLD AND ABOVE
Standard dose
— Chemotherapy induced nausea and vomiting (CINV) – Intravenous:
Prevention:
1-3 mg (10-40 mcg/kg) as a slow intravenous injection (over 30 seconds) or as an intravenous infusion diluted in 20 to 50 ml infusion fluid and administered over 5 minutes, prior to the start of chemotherapy.
Treatment:
1-3 mg (10-40 mcg/kg) as a slow intravenous injection (over 30 seconds) or as an intravenous infusion diluted in 20 to 50 ml infusion fluid and administered over 5 minutes.
Maximum dose over 24 hours:
9 mg.
Chemotherapy induced nausea and vomiting (CINV) – Intramuscular:
Prevention and treatment:
3 mg, 15 minutes prior to the start of chemotherapy.
— Radiotherapy induced nausea and vomiting (RINV):
Prevention:
1-3 mg (10-40 mcg/kg) of granisetron should be administered either as a slow intravenous injection (over 30 seconds) or as an intravenous infusion diluted in 20 to 50 ml infusion fluid and administered over 5 minutes, prior to the start of radiotherapy.
— Post-operative nausea and vomiting (PONV):
Prevention:
1 mg (10 mcg/kg) of granisetron should be administered as a slow intravenous injection (over 30 seconds) prior to induction of anesthesia.
Treatment:
1 mg (10 mcg/kg) of granisetron should be administered by slow intravenous injection (over 30 seconds).
Maximum dose for patients undergoing anesthesia for surgery:
3 mg in one day.
0 TO 18 YEARS OLD
Standard dose
— Chemotherapy induced nausea and vomiting (CINV) – Intravenous:
10-40 mcg/kg body weight (up to 3 mg) as an intravenous infusion diluted in 10-30 ml infusion fluid and administered over 5 minutes prior to the start of chemotherapy.
— Chemotherapy induced nausea and vomiting (CINV) – Intramuscular:
Insufficient data
— Radiotherapy induced nausea and vomiting (RINV):
Insufficient data
— Post-operative nausea and vomiting (PONV):
Insufficient data
ELDERLY PATIENTS
No special dosage recommended for this group.
PATIENTS WITH HEPATIC IMPAIRMENT
No special dosage recommended for this group.
PATIENTS WITH RENAL IMPAIRMENT
No special dosage recommended for this group.
Indication
Granisetron is indicated for the prevention and treatment (control) of:
– Acute and delayed nausea and vomiting associated with chemotherapy and radiotherapy.
– Postoperative nausea and vomiting.